These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Characteristics of Sjögren's syndrome in rheumatoid arthritis. He J; Ding Y; Feng M; Guo J; Sun X; Zhao J; Yu D; Li Z Rheumatology (Oxford); 2013 Jun; 52(6):1084-9. PubMed ID: 23382356 [TBL] [Abstract][Full Text] [Related]
28. Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. Molina R; Provost TT; Arnett FC; Bias WB; Hochberg MC; Wilson RW; Alexander EL Am J Med; 1986 Jan; 80(1):23-31. PubMed ID: 2417478 [TBL] [Abstract][Full Text] [Related]
29. Nervous system disease, immunological features, and HLA phenotype in Sjögren's syndrome. Hietaharju A; Korpela M; Ilonen J; Frey H Ann Rheum Dis; 1992 Apr; 51(4):506-9. PubMed ID: 1586250 [TBL] [Abstract][Full Text] [Related]
30. HLA class I and II, interferon, interleukin 2, and the interleukin 2 receptor expression on labial biopsy specimens from patients with Sjögren's syndrome. Rowe D; Griffiths M; Stewart J; Novick D; Beverley PC; Isenberg DA Ann Rheum Dis; 1987 Aug; 46(8):580-6. PubMed ID: 2444171 [TBL] [Abstract][Full Text] [Related]
31. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis. Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099 [TBL] [Abstract][Full Text] [Related]
32. Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome. Jamin C; Lamour A; Pennec YL; Hirn M; Le Goff P; Youinou P Clin Exp Immunol; 1993 May; 92(2):245-50. PubMed ID: 7683586 [TBL] [Abstract][Full Text] [Related]
33. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478 [TBL] [Abstract][Full Text] [Related]
36. Th1 and Th2 polymorphisms in Sjögren's syndrome and rheumatoid arthritis. de Souza TR; de Albuquerque Tavares Carvalho A; Duarte ÂP; Porter SR; Leão JC; Gueiros LA J Oral Pathol Med; 2014 Jul; 43(6):418-26. PubMed ID: 24393164 [TBL] [Abstract][Full Text] [Related]
37. Activation antigens expressed on T-cells of the peripheral blood in Sjögren's syndrome and rheumatoid arthritis. Ichikawa Y; Shimizu H; Yoshida M; Arimori S Clin Exp Rheumatol; 1990; 8(3):243-9. PubMed ID: 1974181 [TBL] [Abstract][Full Text] [Related]
38. [Detection of serum anti-salivary duct antibody and its clinical significance]. Zhang H; Shi GY; Cai XH Zhonghua Nei Ke Za Zhi; 1990 Nov; 29(11):666-8, 702. PubMed ID: 2086008 [TBL] [Abstract][Full Text] [Related]
39. Predictive value of SS-B precipitating antibodies in Sjoögren's syndrome. Isenberg DA; Hammond L; Fisher C; Griffiths M; Stewart J; Bottazzo GF Br Med J (Clin Res Ed); 1982 Jun; 284(6331):1738-40. PubMed ID: 6805691 [TBL] [Abstract][Full Text] [Related]
40. Antiperinuclear factor in Sjögren's syndrome in the presence or absence of rheumatoid arthritis. Youinou P; Pennec Y; Le Goff P; Ferec C; Morrow WJ; Le Menn G Clin Exp Rheumatol; 1984; 2(1):5-9. PubMed ID: 6335861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]